Abstract
Adipose tissue plays a central role in the development of obesity, and thus characterization of the molecular changes related to obesity in this tissue is a main concern. Recently we identified chitosan oligosaccharides (CO) as a potent adipogenic inhibitor in 3T3-L1 cells. In the current study, a proteomic approach was used to investigate the anti-obesity effect of CO in white adipose tissue of ob/ob mice. CO administration significantly lowered body weight gain and epididymal WAT mass compared to control animals. In addition, twenty-five proteins were found to be differentially expressed between the two groups of animals in response to CO treatment. Expression changes in Karyopherin beta 1, indoleamine-pyrrole 2,3-dioxygenase, and retinoic acid binding protein were associated here for the first time with obesity. Immunoblotting studies of adipocyte protein 2 (aP2) and aquaporin-7 also showed amelioration in their levels in WAT. Furthermore, the results of adipose tissue specific gene expressions of aP2, adiponectin, TNF-α, and IL-6 were in good agreement with improved levels of obesity. Gene expression of PPARg and SREBP-1c were also down-regulated by CO treatment. The results suggest that the anti-obesity effect of CO might be mediated by the modulation of adipokines and adipose tissue specific genes.
Similar content being viewed by others
References
Grundy, S. M. (2004) Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 89: 2595–2600.
Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404: 635–643.
Moller, D. E. and K. D. Kaufman (2005) Metabolic syndrome: A clinical and molecular perspective. Annu. Rev. Med. 56: 45–62.
Chaldakov, G. N., I. S. Stankulov, M. Hristova, and P. I. Ghenev (2003) Adipobiology of disease: Adipokines and adipokines-targeted pharmacology. Curr. Pharm. Des. 9: 1023–1031.
Kershaw, E. E. and J. S. Flier (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89: 2548–2556.
Wassink, A. M., J. K. Olijhoek, and F. L. Visseren (2007) The metabolic syndrome: metabolic changes with vascular consequences. Eur. J. Clin. Invest. 37: 8–17.
Ajjan, R. A. and P. J. Grant (2006) Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents. Diab. Vasc. Dis. Res. 3: 147–158.
Weigle, D. S. (2003) Pharmacological therapy of obesity: Past, present, and future. J. Clin. Endocrinol. Metab. 88: 2462–2469.
Huang, C., Y. Zhang, Z. Gong, X. Sheng, Z. Li, W. Zhang, and Y. Qin (2006) Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway. Biochem. Biophys. Res. Commun. 348: 571–578.
Jeon, T., S. G. Hwang, S. Hirai, T. Matsui, H. Yano, T. Kawada, B. O. Lim, and D. K. Park (2004) Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sci. 75: 3195–3203.
Kim, J. H., D. H. Hahm, D. C. Yang, J. H. Kim, H. J. Lee, and I. Shim (2005) Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharmacol. Sci. 97: 124–131.
Ono, Y., E. Hattori, Y. Fukaya, S. Imai, and Y. Ohizumi (2006) Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J. Ethnopharmacol. 106: 238–244.
Kumar, M. N. V. (2000) A review of chitin and chitosan applications. React. Funct. Polym. 46: 1–27.
Pae, H. O., W. G. Seo, N. Y. Kim, G. S. Oh, G. E. Kim, Y. H. Kim, H. J. Kwak, Y. G. Yun, C. D. Jun, and H. T. Chung (2001) Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leuk. Res. 25: 339–346.
Yoon, H. J., M. E. Moon, H. S. Park, S. Y. Im, and Y. H. Kim (2007) Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun. 358: 954–959.
Lee, J. H., D. H. Lee, J. H. Son, J. K. Park, and S. K. Kim (2005) Optimization of chitosan-alginate encapsulation process using pig hepatocytes for development of bioartificial liver. J. Microbiol. Biotechnol. 15: 7–13.
Singla, A. K. and M. Chawla (2001) Chitosan: Some pharmaceutical and biological aspects — an update. J. Pharm. Pharmacol. 53: 1047–1067.
Hayashi, K. and M. Ito (2002) Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull. 25: 188–192.
Sumiyoshi, M. and Y. Kimura (2006) Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet longterm in mice. J. Pharm. Pharmacol. 58: 201–207.
Houseknecht, K. L., C. A. Baile, R. L. Matteri, and M. E. Spurlock (1998) The biology of leptin: A review. J. Anim. Sci. 76: 1405–1420.
Van den Hoek, A. M., B. Teusink, P. J. Voshol, L. M. Havekes, J. A. Romijn, and H. Pijl (2008) Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J. Neuroendocrinol. 20: 120–127.
Aebersold, R. and M. Mann (2003) Mass spectrometry-based proteomics. Nature 422: 198–207.
Barceló-Batllori, S., H. Corominola, M. Claret, I. Canals, J. Guinovart, and R. Gomis (2005) Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics 18: 4927–4935.
Rahman, A., S. G. Kumar, S. W. Kim, H. J. Hwang, Y. M. Baek, S. H. Lee, H. S. Hwang, Y. H. Shon, K. S. Nam, and J. W. Yun (2008) Proteomic analysis for inhibitory effect of chitosan oligosaccharides on 3T3-L1 adipocyte differentiation. Proteomics 8: 569–581.
Adachi, J., C. Kumar, Y. Zhang, and M. Mann (2007) In-depth Analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell. Proteomics. 6: 1257–1273.
Choi, K. L., Y. Wang, C. A. Tse, K. S. Lam, G. J. Cooper, and A. Xu (2004) Proteomic analysis of adipocyte differentiation: Evidence that α2 macroglobulin is involved in the adipose conversion of 3T3 L1 preadipocytes. Proteomics 4: 1840–1848.
Kratchmarova, I., D. E. Kalume, B. Blagoev, P. E. Scherer, A. V. Podtelejnikov, H. Molina, P. E. Bickel, J. S. Andersen, M. M. Fernandez, J. Bunkenborg, P. Roepstorff, K. Kristiansen, H. F. Lodish, M. Mann, and A. Pandey (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 1: 213–222.
Lanne, B., B. Dahlöf, C. Lindahl, K. Ebefors, I. Kanmert, H. V. Bahr, T. Miliotis, A. C. Nyström, G. Arnerup, I. Paulsons, S. Kerb, and N. Oakes (2006) PPARα and PPARγ regulation of liver and adipose proteins in obese and dyslipidemic rodents. J. Prot. Res. 5: 1850–1859.
Lee, H. K., B. H. Lee, S. A. Park, and C. W. Kim (2006) The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis. Proteomics 6: 1223–1229.
Renes, J., F. Bouwman, J. P. Noben, C. Evelo, J. Robben, and E. Mariman (2005) Protein profiling of 3T3-L1 adipocyte differentiation and (tumor necrosis factor α-mediated) starvation. Cell. Mol. Life Sci. 62: 492–503.
Schmid, G. M., V. Converset, N. Walter, M. V. Sennitt, K. Y. Leung, H. Byers, M. Ward, D. F. Hochstrasser, M. A. Cawthorne, and J. C. Sanchez (2004) Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 4: 2270–2282.
Welsh, G. I., M. R. Griffiths, K. J. Webster, M. J. Page, and J. M. Tavare (2004) Proteome analysis of adipogenesis. Proteomics 4: 1042–1051.
Cho, E. J., M. A. Rahman, S. W. Kim, Y. M. Baek, H. J. Hwang, J. Y. Oh, H. S. Hwang, S. H. Lee, and J. W. Yun (2008) Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J. Microbiol. Biotechnol. 18: 80–87.
Kumar, S. G., M. A. Rahman, S. H. Lee, H. S. Hwang, H. A. Kim, and J. W. Yun (2009) Plasma proteome analysis for antiobesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9: 2149–2162.
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
Shevchenko, A., M. Wilm, O. Vorm, and M. Mann (1996) Mass spectrometric sequencing of proteins from silver stained gels. Anal. Chem. 68: 850–858.
Han, L. K., Y. Kimura, and H. Okuda (1999) Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 23: 174–179.
Flachs, P., V. Mohamed-Ali, O. Horakova, M. Rossmeisl, M. J. Hosseinzadeh-Attar, M. Hensler, J. Ruzickova, and J. Kopecky (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394–397.
Gault, V. A., P. L. McClean, R. S. Cassidy, N. Irwin, and P. R. Flatt (2007) Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 50: 1752–1762.
Weisberg, S. P., R. Leibel, and D. V. Tortoriello (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinol. 149: 3549–3558.
Costantino, L., G. Rastelli, P. Vianello, G. Cignarella, and D. Barlocco (1999) Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches. Med. Res. Rev. 19: 3–23.
Unoki, H., H. Bujo, S. Yamagishi, M. Takeuchi, T. Imaizumi, and Y. Saito (2007) Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diab. Res. Clin. Pract. 76: 236–244.
Brandacher, G., E. Hoeller, D. Fuchs, and H. G. Weiss (2007) Chronic immune activation underlies morbid obesity: Is IDO a key player? Curr. Drug. Metab. 8: 289–295.
Brandacher, G., C. Winkler, F. Aigner, H. Schwelberger, K. Schroecksnadel, R. Margreiter, D. Fuchs, and H. G. Weiss (2006) Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes. Surg. 16: 541–548.
Young, J. C., V. R. Agashe, K. Siegers, and F. U. Hartl (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell. Biol. 5: 781–791.
Kurucz, I., A. Morva, A. Vaag, K. Eriksson, X. Huang, L. Groop, and L. Koranyi (2002) Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51: 1102–1109.
Ozcan, U., Q. Cao, E. Yilmaz, A. H. Lee, N. N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Gorgun, L. H. Glimcher, and G. S. Hotamisligil (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457–461.
Teichert-Kuliszewska, K., B. S. Hamilton, D. A. Roncari, J. L. Kirkland, W. S. Gillon, M. Deitel, and C. H. Hollenberg (1996) Increasing vimentin expression associated with differentiation of human and rat preadipocytes. Int. J. Obes. Relat. Metab. Disord. 3: 108–113.
Marchesan, D., M. Rutberg, L. Andersson, L. Asp, T. Larsson, J. Borén, B. R. Johansson, and S. O. Olofsson (2003) A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J. Biol. Chem. 278: 27293–27300.
Schwarz, E. J., M. J. Reginato, D. Shao, S. L. Krakow, and M. A. Lazar (1997) Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol. Cell. Biol. 17: 1552–1561.
MacDougald, O. A. and M. D. Lane (1995) Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64: 345–373.
MacDougald, O. A. and C. F. Burant (2005) Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter. Proc. Natl. Acad. Sci. USA. 102: 10759–10760.
Reshef, L., Y. Olswang, H. Cassuto, B. Blum, C. M. Croniger, S. C. Kalhan, S. M. Tilghman, and R. W. Hanson (2003) Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278: 30413–30416.
Hibuse, T., N. Maeda, T. Funahashi, K. Yamamoto, A. Nagasawa, W. Mizunoya, K. Kishida, K. Inoue, H. Kuriyama, T. Nakamura, T. Fushiki, S. Kihara, and I. Shimomura (2005) Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc. Natl. Acad. Sci. USA. 102: 10993–10998.
Fruhbeck, G. (2005) Obesity: Aquaporin enters the picture. Nature 438: 436–437.
Fruhbeck, G., V. Catalan, J. Gomez-Ambrosi, and A. Rodrıguez (2006) Aquaporin and glycerol permeability as novel obesity drug-target pathways. Trends. Pharmacol. Sci. 27: 345–347.
Hotamisligil, G. S., P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95: 2409–2415.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259: 87–91.
Fried, S. K., D. A. Bunkin, and A. S. Greenberg (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83: 847–850.
Mohamed-Ali, V., S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82: 4196–4200.
Straub, R. H., H. W. Hense, T. Andus, J. Scholmerich, G. A. Riegger, and H. Schunkert (2000) Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study. J. Clin. Endocrinol. Metab. 85: 1340–1344.
Muller, S., S. Martin, W. Koenig, P. Hanifi-Moghaddam, W. Rathmann, B. Haastert, G. Giani, T. Illig, B. Thorand, and H. Kolb (2002) Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 45: 805–812.
Kado, S., T. Nagase, and N. Nagata (1999) Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta. Diabetol. 36: 67–72.
Fasshauer, M., S. Kralisch, M. Klier, U. Lossner, M. Bluher, J. Klein, and R. Paschke (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 301: 1045–1050.
Yoon, H. J., H. S. Park, H. S. Bom, Y. B. Roh, J. S. Kim, and Y. H. Kim (2005) Chitosan oligosaccharide inhibits 203HgCl2-induced genotoxicity in mice: Micronuclei occurrence and chromosomal aberration. Arch. Pharm. Res. 28: 1079–1085.
Kim, H. M., S. H. Hong, S. J. Yoo, K. S. Baek, Y. J. Jeon, and S. Y. Choung (2006) Differential effects of chitooligosaccharides on serum cytokine levels in aged subjects. J. Med. Food. 9: 427–430.
Harp, J. B. (2004) New insights into inhibitors of adipogenesis. Curr. Opin. Lipidol. 15: 303–307.
Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman (2000) Transcriptional regulation of adipogenesis. Genes. Dev. 14: 1293–1307.
Juvet, L. K., S. M. Andresen, G. U. Schuster, K. T. Dalen, K. A. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, J. A. Gustafsson, and H. I. Nebb (2003) On the role of liver X receptors in lipid accumulation in adipocytes. Mol. Endocrinol. 17: 172–182.
Seo, J. B., H. M. Moon, W. S. Kim, Y. S. Lee, H. W. Jeong, E. J. Yoo, J. Ham, H. Kang, M. G. Park, K. R. Steffensen, T. M. Stulnig, J. A. Gustafsson, S. D. Park, and J. B. Kim (2004) Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 24: 3430–3444.
Tamori, Y., J. Masugi, N. Nishino, and M. Kasuga (2002) Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045–2055.
Fajas, L., J. C. Fruchart, and J. Auwerx (1998) Transcriptional control of adipogenesis. Curr. Opin. Cell. Biol. 10: 165–173.
Rousseau, V., D. J. Becker, L. N. Ongemba, J. Rahier, J. C. Henquin, and S. M. Brichard (1997) Developmental and nutritional changes of job and PPAR gamma 2 gene expression in rat white adipose tissue. J. Biochem. 321: 451–456.
Gregoire, F. M., C. M. Smas, and H. S. Sul (1998) Understanding adipocyte differentiation. Physiol. Rev. 78: 783–809.
Kim, J. B. and B. M. Spiegelman (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes. Dev. 10: 1096–1107.
Tontonoz, P., J. B. Kim, R. A. Graves, and B. M. Spiegelman (1993) ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13: 4753–4759.
Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards (1999) Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J. Biol. Chem. 274: 20603–20610.
Hsu, C. L. and G. C. Yen (2007) Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food. Chem. 55: 8404–8410.
Yang, J. Y., M. A. Della-Fera, S. Rayalam, S. Ambati, D. L. Hartzell, H. J. Park, and C. A. Baile (2008) Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82: 1032–1039.
Margareto, J., E. Larrarte, A. Marti, and J. A. Martinez (2001) Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: Possible features of the antiobesity effects of a beta3-adrenergic agonist. Biochem. Pharmacol. 61: 1471–1478.
Lee, Y. S., W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J. M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, C. Hohnen-Behrens, A. Gosby, E. W. Kraegen, D. E. James, J. B. Kim (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55: 2256–2264.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rahman, M.A., Kumar, S.G. & Yun, J.W. Proteome analysis in adipose tissue of ob/ob mice in response to chitosan oligosaccharides treatment. Biotechnol Bioproc E 15, 559–571 (2010). https://doi.org/10.1007/s12257-009-3135-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-009-3135-8